Stent vs. Stent-less Ileal Conduits After Radical Cystectomies: Is There Difference In Early Postoperative Outcomes?
Rishabh K. Simhal, MD; Daniel Givner, BS; Kerith Wang, BA; Yash B. Shah; Zachary Prebay, MD; Daniel P. Simon, MD; Costas D. Lallas, MD; Leonard G. Gomella, MD; and Mihir M. Shah, MD
Placing ureteral stents at the ureteroileal anastomosis for radical cystectomy with ileal conduit (RCIC) diversion has long been common practice, which has recently been called into question. In this study, we aim to investigate the difference in 30-day outcomes between patients who did and did not receive ureteral stents after RCIC.
Large Scale Implementation of Opioid Prescription Reduction After Robotic Prostatectomy – 2 Year Evaluation from the Pennsylvania Urologic Collaborative (PURC)
Thenappan Chandrasekar, Necole M. Streeper, Charles Keith, Andrea Quinn, Kaynaat Syed, Alexandar Kutikov, John Danella, Serge Ginzburg, Thomas Lanchoney, Jeffery Tomaszewski, Edouard Trabulsi, Adam Reese, Marc Smaldone, Robert Uzzo, Thomas J. Guzzo, Jay D. Raman, Daniel J. Lee, and Adrien Bernstein
To evaluate the impact of institutional opioid reduction protocols for robotic assisted laparoscopic prostatectomy (RALP).
Guide future quality improvement to patient’s postsurgical outcomes.
Overcoming the Learning Curve: A Single Institution Review of HoLEP Complications and How to Manage Them
Cassra Clark, Jared Raikin, Anthony Tokarski, Abhay Singh, Patrick J. Shenot, and Akhil K. Das
We performed a comprehensive retrospective chart review of patients who underwent HoLEP, primarily by a single surgeon, between 2013 and 2020 at our institution. We assessed for 16 complications related to HoLEP and Clavien-Dindo classification grade II and above.
Cassra Clark, Corinne Wessner, Shuo Wang, Andrew Denisenko, Andrew Shumaker, Joonyau Leong, Andrea Quinn, Erica Mann, Lydia Glick, Timothy Han, Kibo Nam, Katherine Smentkowski, John Eisenbrey, Leonard Gomella, Eduard Trabulsi, Costas Lallas, Mark Mann, James Mark, Flemming Forsberg, Andrej Lyshchik, Ethan Halpern, and Thenappan Chandrasekar
We conducted an IRB-approved prospective pilot study evaluating the use of CEUS to calculate tumor fractional vascularity (FV) as a metric to better risk stratify patients.
Printing is not supported at the primary Gallery Thumbnail page. Please first navigate to a specific Image before printing.